Search Results
Dec 23, 2025, 10:21 ET Home Genius Exteriors Expands Executive Leadership Team with Appointment of Suraj Akotia
the business, ensuring regulatory compliance while proactively managing risk as the company expands across the United States."Suraj brings a rare combination of legal expertise, business acumen, and values-driven leadership," said Jeff Gunhus, CEO of Home Genius Exteriors. "I've trusted his judgment
More news about: Home Genius Exteriors
Dec 23, 2025, 10:00 ET NBATrips Unveils 2026 Dream Basketball Journeys: Courtside Action, Iconic Cities, and Unforgettable Experiences
are limited to a maximum of 50 guests, and go far beyond simply watching a game. Highlights include private arena tours, locker-room visits, and the rare opportunity to play a full 5-on-5 game on an official NBA court—placing guests at the heart of the action.NBA journeys with a clear narrative
More news about: NBA Trips
Dec 23, 2025, 09:30 ET CT UNITED FC APPOINTS SHAVAR THOMAS AS FIRST-EVER HEAD COACH
bigger." Denis Hamlett, who played a pivotal role in the coaching search, underscored the significance of the hire. "Shavar has the rare combination of elite playing experience, tactical understanding, and leadership presence," Hamlett said. "He's proven he can win, proven he
More news about: CT United FC
Dec 23, 2025, 09:00 ET James Malcolm Band Sells Out Debut Concert, Sparks Emotional Audience Response, and Surpasses 250,000 Spotify Streams
the venue, with numerous audience members moved to tears.The evening concluded with a standing ovation lasting nearly three minutes, a rare response for a debut concert and a strong indicator of early audience validation.That momentum extended beyond the live event. The following
More news about: Settle Down Productions, LLC
Dec 23, 2025, 09:00 ET Lunit SCOPE Demonstrates High Concordance with Pathologists in HER2 Interpretation for Advanced Biliary Tract Cancer
cancer (BTC) by comparing assessments from pathologists using light microscopy and digital pathology with results generated by Lunit SCOPE HER2. BTC is a rare and aggressive cancer in which accurate biomarker evaluation is critical for identifying patients who may benefit from HER2-targeted therapies.Conducted
More news about: Lunit
Dec 23, 2025, 09:00 ET A Slice of Humble Pie: How One Farmer's Harvest-Time Tradition Is Lifting Up Her Community
routine, her deep relationships with the farmers she serves, and the values that guide her work both in the field and in her community. The film offers a rare glimpse into the everyday generosity that helps sustain rural America.In keeping with the spirit of the story, Pivot Bio is also making a donation
More news about: Pivot Bio, Inc
Dec 23, 2025, 08:15 ET AMLM Expands Global Footprint with Strategic Acquisition of High-Grade Gold Projects in Canada and Tanzania
Lithium Materials, Inc. American Lithium Materials, Inc. (OTCID: AMLM)) is an exploration-stage mining company focused on gold, lithium, rare earths, cobalt, nickel, and other critical metals powering the global energy transition. Now entering a transformation phase, AMLM is being repositioned
More news about: American Lithium Minerals, Inc
Dec 23, 2025, 08:00 ET Mulberry Industries, Ramaco Resources Announce the Entry into a Non-Binding Memorandum of Understanding that aims to Strengthen Domestic Rare Earth & Permanent Magnet Supply Chain
leading developer of critical minerals and rare earth elements at its Brook Mine in Wyoming, today announce that they have entered into a non-binding memorandum of understanding ("MOU") to negotiate an offtake partnership that will bolster America's domestic rare earth and permanent magnet supply chain.
More news about: Ramaco Resources, Inc.
Dec 23, 2025, 08:00 ET High Tide Recaps Key Milestones of 2025
Tide as we evolved from a domestic market leader into a global cannabis company. Achieving strong growth while remaining free cash flow positive is rare in any retail category, and it reflects the strength of our operating model, disciplined execution, and the dedication of our team. Growing from a single
More news about: High Tide Inc.
Dec 23, 2025, 07:00 ET Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference
/PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined continued progress across its AI-enabled drug development platform at its 2025 annual investor conference,
More news about: Senhwa Biosciences, Inc.
Dec 23, 2025, 06:00 ET Calling All Trailblazers: Introducing the Inaugural "PropTech Startup Showdown" at SXSW 2026
contech, property management, data and AI, and agent tools. Finalists will give rapid-fire presentations and get real-time feedback. The Showdown offers a rare opportunity for founders to capture the attention of leading voices across National Association of Realtors® Tech & Innovation, Realtor.com®,
More news about: Realtor.com
Dec 22, 2025, 22:56 ET GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea
R&D capabilities in engineering of proteins, mRNAs, and lipid nanoparticle (LNP) drug delivery platform to develop therapeutics for the field of rare disease as well as I&I (Immunology & Inflammation). To learn more about the company, visit
More news about: GC Biopharma
Dec 22, 2025, 20:08 ET Harris Cyber Policy Initiative Taps Top Hacker to Design New Security Model for Water Utilities
expertise, and real-world perspective needed to build a managed security model that actually works for water operators on the ground."Wheeler brings a rare interdisciplinary background to the role. An information security executive, AI researcher specializing in natural language processing, and social data
More news about: DEF CON Franklin
Dec 22, 2025, 18:03 ET FDA approves Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and
More news about: NOVO NORDISK INC.
Dec 22, 2025, 10:30 ET Consult PR Inc. Announces Consecutive Years of 100+ Annual Awards
announced that it received a whopping 114 awards and recognitions in 2025. This follows more than 100 awards in 2024 and reflects an achievement that is rare in the digital services industry for a company offering custom software, digital marketing, and custom websites under one roof.
More news about: Consult PR, Inc.
Dec 22, 2025, 10:15 ET Single-molecule Real-time (SMRT) Sequencing worth $5.32 billion by 2030| MarketsandMarkets™
sequencing market in North America is growing rapidly as labs, hospitals, and genome centers turn to long-read data to tackle challenging problems, such as rare-disease diagnosis and complex cancer genomics. Strong public funding and active collaboration among universities, consortia, and industry are accelerating
More news about: MarketsandMarkets
Dec 22, 2025, 10:01 ET Next-generation Sequencing Services Market worth $8.77 billion by 2030 | MarketsandMarkets™
market. The growth of the market can be attributed to the rapid expansion of outsourced sequencing for oncologic profiling, hereditary disease testing, rare disease workups, and infectious disease surveillance in routine clinical practice. Additional growth is supported by increasing drug reimbursement for
More news about: MarketsandMarkets
Dec 22, 2025, 09:12 ET Tanabe Pharma America Announces Transfer of RADICAVA® Business to Shionogi
transaction is intended to support the long-term growth and sustainability of the brand by aligning it with a company that has a strong strategic focus on rare diseases and long-term commitment to the ALS community."As the company that helped bring RADICAVA® to patients in the United States
More news about: Tanabe Pharma America
Dec 22, 2025, 09:00 ET Promontory Therapeutics Announces Interim Efficacy Requirement Reached on Phase 2 Study of PT-112 Monotherapy in Patients with Recurrent Thymoma
the National Cancer Institute under a Collaborative Research and Development Agreement, assessing PT-112 monotherapy in thymic epithelial tumors, a rare disease with no FDA approved drug, for which Promontory holds FDA Orphan Drug designation.CONTACTS:Promontory TherapeuticsEmail:
More news about: Promontory Therapeutics Inc.
Dec 22, 2025, 09:00 ET FedEx and UPS 2026 GRIs Signal Pricing Restraint -- But Parcel Shippers Face a More Complex Cost Reality
annual GRI. After several years in which actual shipper costs significantly outpaced the highly-publicized carrier GRIs, Reveel's modeling shows a rare alignment in 2026 between the headline increase and the expected real-world impact. For many shippers, the 5.9% GRI is closer to what will actually
More news about: Reveel
Dec 22, 2025, 08:32 ET Toxin-to-Treasure: Chonnam National University Scientists Use Engineered Enzyme to Turn Formaldehyde Pollutant into High-Value Chemical
formaldehyde from industrial waste streams but also green chemistry. L-glyceraldehyde is a renewable raw material that serves as a crucial precursor for rare sugars such as L-sorbose and L-psicose and chiral intermediates used in drug development. As a C3 compound, it is a key player in many biochemical pathways.
More news about: Chonnam National University
Dec 22, 2025, 08:18 ET King Resources, Inc. (OTC: KRFG) Subsidiary Heavenly Grace Limited Achieves Major Revenue Milestone with US$574,310 Sale of Rare Collectibles
is pleased to announce that its indirect wholly-owned subsidiary, Heavenly Grace Limited ("HGL"), has successfully completed the sale of five rare collectible artifacts to Mirum Digital Media Limited. This transaction, totaling approximately US$574,310, represents a significant validation
More news about: King Resources, Inc.
Dec 22, 2025, 08:00 ET Etiome Strengthens Leadership Team with Appointment of Jean Lachowicz as Chief Scientific Officer
three decades of drug discovery and development experience to Etiome spanning multiple disease indications including neurology, oncology, immunology, rare disease, and cardiometabolic disease. She most recently served as SVP, Chief Development Scientist at Schrodinger, where she focused on asset strategy
More news about: Etiome, Inc.
Dec 22, 2025, 07:35 ET Messi Jewelry Launches Fancy Color CVD Lab-Grown Diamond Collection to Meet Rising Global Demand for Sustainable Luxury
necklaces or statement rings in canary yellow," said Jimmy Wu, who founded Messi Jewelry seven years ago. "Five years ago, those requests were rare. Now they're daily. Our clients want jewelry that tells their story, not a story someone else wrote for them."Beyond the White Diamond
More news about: WUZHOU MESSI GEMS CO., LTD
Dec 22, 2025, 07:00 ET Defense Metals Provides Joint Letter to Shareholders from Executive Chairman and CEO
transformative year for Defense Metals Corp. as we continued to advance the Wicheeda Rare Earth Project while strengthening our leadership, financial position, and strategic alignment in response to growing global demand for secure rare earth supply.During the year, we enhanced our leadership and governance
More news about: Defense Metals Corp.